Leadership Overview
Agios has 4 executives leading key functions including finance, human resources, legal, and medical strategy.
Driven by scientific innovation, Agios is dedicated to discovering and developing transformative medicines for patients with rare genetic diseases, focusing on the critical role of cellular metabolism.
Driven by scientific innovation, Agios is dedicated to discovering and developing transformative medicines for patients with rare genetic diseases, focusing on the critical role of cellular metabolism.
Leadership Roles at Agios
Cecilia Jones - Chief Financial Officer
Cecilia Jones, the Chief Financial Officer at Agios, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and capital allocation, Jones ensures robust financial health to support the company's drug development pipeline. This leadership role involves managing investor relations and communicating financial performance to stakeholders. By optimizing resource deployment, Cecilia Jones directly supports the advancement of novel therapies like PYRUKYND and pipeline candidates targeting rare diseases. The Chief Financial Officer's strategic guidance is crucial for sustained growth and market positioning in the biopharmaceutical sector, ensuring financial stability for ongoing research and development initiatives across the United States.
Ellen Lopresti - Chief People Officer
Ellen Lopresti, the Chief People Officer at Agios, architects the company's human capital strategy and cultivates a high-performance culture. Overseeing talent acquisition, development, and employee engagement, Lopresti ensures a skilled and motivated workforce dedicated to Agios's mission. This executive position involves fostering an inclusive environment that supports innovation in drug discovery and development. By championing organizational development, Ellen Lopresti directly contributes to the effective execution of strategies for bringing life-changing medicines to patients. The Chief People Officer's focus on people operations is fundamental to Agios's success in the competitive biopharmaceutical landscape, driving employee retention and fostering collaboration across all departments in Cambridge, Massachusetts.
James Burns - Chief Legal Officer
James Burns, the Chief Legal Officer at Agios, provides strategic legal counsel and oversees all corporate governance matters. Directing the legal department, Burns manages intellectual property, regulatory compliance, and litigation, safeguarding the company's assets and interests. This critical role ensures adherence to stringent pharmaceutical regulations across the United States. By mitigating legal risks, James Burns directly supports the advancement of Agios's innovative therapies, including PYRUKYND and pipeline candidates. The Chief Legal Officer's expertise is essential for navigating the complex legal and regulatory frameworks inherent in drug development and commercialization, ensuring the company operates with integrity and compliance.
Sarah Gheuens - Chief Medical Officer & Executive Vice President
Sarah Gheuens, the Chief Medical Officer & Executive Vice President at Agios, spearheads clinical development and medical affairs strategies. Overseeing the design and execution of clinical trials for novel therapeutics, Gheuens drives the advancement of medicines like PYRUKYND and pipeline assets targeting rare genetic diseases. This senior leadership position involves translating scientific insights into effective patient treatments and ensuring medical excellence. By guiding clinical research, Sarah Gheuens directly impacts the successful progression of drug candidates through regulatory pathways. The Chief Medical Officer's deep medical expertise is paramount to Agios's mission of delivering transformative therapies, shaping the future of treatment for hemolytic anemias and other metabolic disorders.
Explore Leadership Teams in Manufacturing
Founded in 1989, Macleods Pharmaceutical develops and manufactures generic pharmaceuticals. The Company offers tablets, drugs, syrup, and other related products. The company is headquartered in Mumbai, Maharashtra, India.
Company Leadership AP
BP
AM
AS
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited's investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies we believe makes us a partner of choice for innovator and generic companies worldwide.
Company Leadership SL
BC
RM
Renata Limited is a pharmaceutical and animal health product manufacturing company headquartered in Dhaka, Bangladesh. Their products include a variety of human pharmaceuticals, including synthetic hormones, oncological drugs, contraceptives, and more, as well as animal health and nutrition products. The company was founded in 1972 as Pfizer Bangladesh and changed ownership and name to Renata Limited in 1993.
Company Leadership NA
MA
At Simtra, the company is dedicated to developing and manufacturing quality sterile injectable products to meet evolving patient needs. The company works with precision and transparency, setting high standards and paying attention to every detail, in order to ensure that the company makes your product right the first time, deliver it on time and meet your requirements in full. The company is made for this, with the company's extensive slate of services and product delivery options.
Company Leadership
TD
RG
Frequently Asked Questions Regarding Agios Top Executives and Leadership Team
